AdvanSix vs Hexcel
ASIX and HXL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASIX and HXL compare
Hexcel is the larger company, worth 14 times as much as AdvanSix ($5.8B against $399M).
Hexcel grew revenue faster over the last twelve months (7.6% versus 3.0% for AdvanSix).
Hexcel keeps more of each dollar of sales as profit, with a net margin of 8.5% compared with −1.1% at AdvanSix.
Both pay dividends: AdvanSix yields 4.3% and Hexcel 0.71%.
Hexcel scores higher on the StockData Score (14 against 11 for AdvanSix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASIX | HXL |
|---|---|---|
| Size and price | ||
| Market cap | $399M | $5.8B |
| Share price | $14.78 | $76.42 |
| Change, 1 year | −5.9% | 10.6% |
| Change, 5 years | −68.5% | 43.5% |
| Beta (5Y) | −1.42 | 0.69 |
| Employees | 1,410 | 5,563 |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 0 | 3 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | – | 34.3× |
| P/S | 0.3× (better) | 2.9× |
| P/B | 0.5× (better) | 4.4× |
| EV/EBITDA | – | 18.1× |
| P/FCF | – | 27.6× |
| FCF yield | −6.5% | 3.6% (better) |
| Fair value | $36.22 | $68.15 |
| Margin of safety | 59.2% (better) | −12.1% |
| Growth | ||
| Revenue growth (TTM) | 3.0% | 7.6% (better) |
| Revenue growth, 5Y average | 5.6% (better) | 4.7% |
| Net income growth (TTM) | −123% | 149% (better) |
| EPS growth (TTM) | −123% | 162% (better) |
| EPS growth, 5Y average | 1.9% | – |
| Profitability | ||
| Gross margin | 5.6% | 25.2% (better) |
| Operating margin | – | 12.2% |
| Net margin | −1.1% | 8.5% (better) |
| FCF margin | −1.7% | 10.4% (better) |
| Return on equity | −2.2% | 11.9% (better) |
| Return on invested capital | – | 8.8% |
| Financial health | ||
| Debt / equity | 0.00 | 0.71 (better) |
| Net debt / EBITDA | – | 2.33 |
| Interest coverage | – | 5.2× |
| Current ratio | 1.28 | 2.57 (better) |
| Altman Z-score | 1.81 | 4.95 (better) |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 4.3% (better) | 0.71% |
| Payout ratio | – | 31.4% |
| Years of dividend growth | – | 3 |
| Dividend growth, 5Y average | – | 32.0% |
| Buyback yield | 0.31% | 6.1% (better) |
| Shareholder yield | 4.6% | 6.8% (better) |
| Ownership | ||
| Held by institutions | 91.7% | 114% |
| Held by insiders | 4.6% | 1.0% |
| Insider net buying, 12 months | – | −$2.1M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.1% | 7.1% |
Go deeper
- ASIX stock overview
- ASIX income statement
- ASIX valuation and score
- HXL stock overview
- HXL income statement
- HXL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.